Guitar News »

1
Vote
Discuss  | |  Bury
HONG KONG (Reuters) - Researchers in Japan have designed a test to identify patients who are likely to be resistant to imatinib, the standard drug for treating leukemia or cancer of the blood cells.

Who Voted for this Story

  1. Avatar willwpms

Comments

No one has commented on this article yet.

Log in to comment or register here.